COVID-19 Antibody Test Kits for Health Care Workers
Sourcing highly reliable antibody test-kits for health care workers & first responders
About the Project
Verboden Labs is helping hospitals and heath care clinics access highly reliable and cost-effective COVID-19 Antibody Detection Tests to test as many front line workers as possible. A test for antibodies that produces results within 15 minutes especially in people that didn't even know they had it, is a crucial part of the public health strategy and its impact could be enormous.
We need your help with the following tasks:
1. App developers to create an app that interprets test results
2. Identify and reach out to hospitals and medical clinics
3. Create infographics for social media posts and email campaigns
ABOUT THE TEST
The SARS-CoV-2 IgM/IgG Antibody Rapid Test is an in-vitro diagnostic immunochromatographic assay used in the detection of SARS-CoV-2 antibodies (IgM and IgG) in whole blood or serum from individuals who are suspected of COVID-19 infection but display little to no symptoms. With only two drops of blood from the fingertip, the test can determine the presence of immunoglobulins IgM and IgG, which are found in the blood of people who have been exposed to the SARS-CoV-2 virus. With clear results in 15 minutes, healthcare professionals can make a quick, reliable diagnosis without the need for a laboratory. Precious time will be saved that will help contain the further spread of the virus. This test is most accurate in detecting antibody levels in patients after at least 14 days after the onset of symptoms.
HOW IT WORKS
When the body is exposed to a virus, the immune system begins to produce antibodies to fight the virus and future infections from it. Those antibodies remain behind after the virus is cleared from the body, which the tests detect. This confirms a previous infection. These tests could be especially useful for determining whether health care workers have some immunity and are at lower risk if they go back to work. Unlike other COVID-19 tests, the CoV-2 Rapid test can also determine current infection phase. A positive IgM value indicates an infection in the early phase of the disease (4 to 10 days), and a positive IgG value indicates a later phase (from 11 - 24 days).
YALE UNIVERSITY STUDY
A Yale University study concluded that this test is suitable for detecting IgM and IgG antibodies to SARS-CoV-2 with high levels of sensitivity and specificity. IgG specificity is near-perfect (99.7-100%) over the entire cohort of 1,892 patient samples. This finding provides reassurance that this test will minimize the chance for false positive results.
After months of research and a vetting, Verboden has signed an agreement with Biohit Healthcare to provide reliable and cost-efficient test kits that makes broad-scale testing to be possible.
- Who is already working on this
- Helpful links
- How to get in touch
- Number of volunteers needed
- Preferred Volunteer location
- Organization status